ENTRY       D12055                      Drug
NAME        Sotorasib (JAN/USAN);
            Lumakras (TN)
PRODUCT     LUMAKRAS (Amgen)
FORMULA     C30H30F2N6O3
EXACT_MASS  560.2347
MOL_WEIGHT  560.5944
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01XX73
            Product: D12055<JP/US>
EFFICACY    Antineoplastic
  DISEASE   Non-small cell lung cancer (KRAS G12C-mutated) [DS:H00014]
TARGET      KRAS* [HSA_VAR:3845v1] [HSA:3845] [KO:K07827]
  PATHWAY   hsa04014(3845)  Ras signaling pathway
            hsa04151(3845)  PI3K-Akt signaling pathway
            hsa05200(3845)  Pathways in cancer
            hsa05223(3845)  Non-small cell lung cancer
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX73 Sotorasib
                  D12055  Sotorasib (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Sotorasib
                D12055  Sotorasib (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D12055  Sotorasib (JAN/USAN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D12055  Sotorasib
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               G protein
                KRAS* [HSA_VAR:3845v1]
                 D12055  Sotorasib (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D12055
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D12055
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12055
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D12055
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D12055
DBLINKS     CAS: 2296729-00-3
            ChEBI: 178199
ATOM        41
            1   C8y C    14.4900  -15.4700
            2   C8y C    14.4900  -16.8700
            3   C8x C    15.7024  -17.5700
            4   C8y C    16.9149  -16.8700
            5   C8y C    16.9149  -15.4700
            6   N5x N    15.7024  -14.7700
            7   C8y C    18.1273  -17.5700
            8   N5x N    19.3397  -16.8700
            9   C8y C    19.3397  -15.4700
            10  N4y N    18.1273  -14.7700
            11  X   F    13.2776  -17.5700
            12  C8y C    13.2776  -14.7700
            13  C8y C    13.2776  -13.3702
            14  C8x C    12.0651  -12.6702
            15  C8x C    10.8527  -13.3702
            16  C8x C    10.8527  -14.7700
            17  C8y C    12.0651  -15.4700
            18  X   F    12.0651  -16.8698
            19  O1a O    14.5068  -12.6603
            20  O5x O    20.5373  -14.7785
            21  C8y C    18.1273  -12.3900
            22  C8y C    19.3418  -11.6888
            23  N5x N    19.3418  -10.2888
            24  C8x C    18.1293   -9.5888
            25  C8x C    16.9149  -10.2900
            26  C8y C    16.9149  -11.6900
            27  C1a C    15.7214  -12.3793
            28  C1c C    20.5383  -12.3798
            29  C1a C    21.7251  -11.6946
            30  C1a C    20.5384  -13.7897
            31  N1y N    18.1273  -18.9700
            32  C1x C    16.9169  -19.6688
            33  C1x C    16.9169  -21.0688
            34  N1y N    18.1293  -21.7688
            35  C1x C    19.3397  -21.0700
            36  C1y C    19.3397  -19.6700
            37  C1a C    20.5373  -18.9785
            38  C5a C    18.1293  -23.1700
            39  C2b C    19.3423  -23.8703
            40  O5a O    16.9174  -23.8697
            41  C2a C    19.3423  -25.2698
BOND        45
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    2  11 1
            13    1  12 1
            14   12  13 2
            15   13  14 1
            16   14  15 2
            17   15  16 1
            18   16  17 2
            19   12  17 1
            20   17  18 1
            21   13  19 1
            22    9  20 2
            23   10  21 1
            24   21  22 2
            25   22  23 1
            26   23  24 2
            27   24  25 1
            28   25  26 2
            29   21  26 1
            30   26  27 1
            31   22  28 1
            32   28  29 1
            33   28  30 1
            34    7  31 1
            35   31  32 1
            36   32  33 1
            37   33  34 1
            38   34  35 1
            39   35  36 1
            40   31  36 1
            41   36  37 1
            42   34  38 1
            43   38  39 1
            44   38  40 2
            45   39  41 2
///
